Multivessel percutaneous coronary intervention in patients with acute myocardial infarction and severe renal dysfunction
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, Pil Sang | - |
dc.contributor.author | Hahn, Joo-Yong | - |
dc.contributor.author | Gwon, Hyeon-Cheol | - |
dc.contributor.author | Jeon, Ki-Hyun | - |
dc.contributor.author | Yu, Cheol Woong | - |
dc.contributor.author | Rha, Seung-Woon | - |
dc.contributor.author | Yoon, Chang-Hwan | - |
dc.contributor.author | Jeong, Myung Ho | - |
dc.date.accessioned | 2021-08-31T22:41:31Z | - |
dc.date.available | 2021-08-31T22:41:31Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-12 | - |
dc.identifier.issn | 1774-024X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/61366 | - |
dc.description.abstract | Aims: The aim of this study was to compare the outcomes between multivessel and infarct-related artery (IRA)-only percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI), multivessel disease (MVD), and severe renal dysfunction (RD) using the nationwide AMI registry. Methods and results: Among 13,104 patients, 537 diagnosed with AMI and MVD who had severe RD at presentation (estimated glomerular filtration rate [GFR] <30 mL/min/1.73 m2, mean: 19.1 +/- 7.5 mL/min/1.73 m2) and underwent PCI during index hospitalisation were selected. The patients were classified according to treatment strategy, i.e., multivessel PCI (49.0%) or IRA-only PCI. The primary endpoint was major adverse cardiac events (MACE), a composite of all-cause death, myocardial reinfarction, re-hospitalisation for heart failure, and any repeat revascularisation at one year. The safety outcome was the worsening of renal function (WRF), defined as a 30% reduction in estimated GFR from baseline to 12-month follow-up. The adjusted MACE risks were similar in groups after Cox regression (41.8% vs 39.8%, hazard ratio [HR] 1.008 [0.743-1.367]) and propensity score-matching analysis (HR 0.974 [0.651-1.377]). Multivessel PCI showed a significant tendency of higher rates of WRF (24.8% vs 11.1%, adjusted odds ratio 2.134 [0.976-4.668]). Conclusions: Multivessel PCI was associated with similar outcomes compared to IRA-only PCI in patients with AMI, MVD, and severe RD. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | EUROPA EDITION | - |
dc.subject | RANDOMIZED-TRIAL | - |
dc.subject | CULPRIT LESION | - |
dc.subject | REVASCULARIZATION | - |
dc.subject | ANGIOPLASTY | - |
dc.title | Multivessel percutaneous coronary intervention in patients with acute myocardial infarction and severe renal dysfunction | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yu, Cheol Woong | - |
dc.contributor.affiliatedAuthor | Rha, Seung-Woon | - |
dc.identifier.doi | 10.4244/EIJ-D-19-00034 | - |
dc.identifier.scopusid | 2-s2.0-85085940798 | - |
dc.identifier.wosid | 000501563600015 | - |
dc.identifier.bibliographicCitation | EUROINTERVENTION, v.15, no.11, pp.E1014 - + | - |
dc.relation.isPartOf | EUROINTERVENTION | - |
dc.citation.title | EUROINTERVENTION | - |
dc.citation.volume | 15 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | E1014 | - |
dc.citation.endPage | + | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | RANDOMIZED-TRIAL | - |
dc.subject.keywordPlus | CULPRIT LESION | - |
dc.subject.keywordPlus | REVASCULARIZATION | - |
dc.subject.keywordPlus | ANGIOPLASTY | - |
dc.subject.keywordAuthor | multiple vessel disease | - |
dc.subject.keywordAuthor | non-STEMI | - |
dc.subject.keywordAuthor | renal insufficiency | - |
dc.subject.keywordAuthor | STEMI | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.